Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 2, 2024
[ Tue, Apr 02nd 2024
] - WOPRAI
[ Tue, Apr 02nd 2024
] - WOPRAI
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
Jeff Jones Reiterated (ANTX) at Hold on, Apr 1st, 2024
Jeff Jones of Oppenheimer, Reiterated "AN2 Therapeutics, Inc." (ANTX) at Hold on, Apr 1st, 2024.
Jeff has made no other calls on ANTX in the last 4 months.
There are 3 other peers that have a rating on ANTX. Out of the 3 peers that are also analyzing ANTX, all agree with Jeff's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Joseph Schwartz of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $7 on, Tuesday, February 13th, 2024
- Liisa Bayko of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $7 on, Monday, February 12th, 2024
- Roy Buchanan of "JMP Securities" Downgraded from Buy to Hold on, Monday, February 12th, 2024
